Screening before surrogacy treatment
The genetic woman, genetic couple, female host and host couple, must all be screened before beginning surrogacy treatment. The genetic woman may have blood tests and ultrasound scans to assess her ovaries and ovarian function.
The genetic couple may have their blood group and Rhesus (Rh) status determined, if the hosts blood is Rhesus negative. The genetic couple are also screened for HIV (AIDS), hepatitis B and C to ensure that neither the host nor the child is at risk.
The female hosts blood group and Rhesus status is determined. While the host couple is screened for HIV, hepatitis B and C.